ResearcherSecond Affiliated Hospital of Soochow UniversityNo recent work listed

Zhiwei Gu

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5062778429. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2019: 1 paper · 2020: 1 paper

Papers 2

Downregulation of USP34 Inhibits the Growth and Migration of Pancreatic Cancer Cells via Inhibiting the PRR11. Co-author DOI 10.2147/ott.s228857 ↗
USP34 Regulated Human Pancreatic Cancer Cell Survival via AKT and PKC Pathways. Co-author DOI 10.1248/bpb.b18-00646 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Dekang Gao · 2 shared papers, 2019–2020 · strength 0.25
- Paper Downregulation of USP34 Inhibits the Growth and Migration of Pancreatic Cancer Cells via Inhibiting the PRR11. DOI 10.2147/ott.s228857 ↗
- Paper USP34 Regulated Human Pancreatic Cancer Cell Survival via AKT and PKC Pathways. DOI 10.1248/bpb.b18-00646 ↗
Shaohua Wei · 2 shared papers, 2019–2020 · strength 0.25
- Paper Downregulation of USP34 Inhibits the Growth and Migration of Pancreatic Cancer Cells via Inhibiting the PRR11. DOI 10.2147/ott.s228857 ↗
- Paper USP34 Regulated Human Pancreatic Cancer Cell Survival via AKT and PKC Pathways. DOI 10.1248/bpb.b18-00646 ↗
Changjie Lin · 2 shared papers, 2019–2020 · strength 0.25
- Paper Downregulation of USP34 Inhibits the Growth and Migration of Pancreatic Cancer Cells via Inhibiting the PRR11. DOI 10.2147/ott.s228857 ↗
- Paper USP34 Regulated Human Pancreatic Cancer Cell Survival via AKT and PKC Pathways. DOI 10.1248/bpb.b18-00646 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.